← Leaderboards
Michael Cecchini
Yale University
$1,304,790
Attributed
$1,304,790
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $261K · FY2021–25$500K$375K$250K$125K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,304,790 · 1
By mechanism
K08$1,304,790 · 1
Top collaborators
No co-investigators on record.
Most similar at Yale University
Same institution · by research overlap
- Ranjit Bindra$5,884,099
- Carrie L. Lucas$8,591,498
- Lilian Carolina Kabeche$1,814,826
- Barbara Burtness$2,957,738
- Juan C Vasquez$1,156,265
Others in their field
Other Emerging Leaders on “Clinical Trial Implementation”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Kimberly Smith · Ppd Development Lp$115,671,664
- Abraham Aizer Brody · New York University School Of Medicine$38,636,725
- Claudia Valmonte · The Emmes Company, Llc$37,865,589
- Bryan Faller · Decatur Memorial Hospital$29,346,991
Research focus
Clinical Trial ImplementationCollaborationsAlkylating Antineoplastic AgentsAdenosine Diphosphate RiboseAlkylating AgentsClinical Trials DesignApoptosisAtr GeneAwardAncillary StudyBase Excision RepairsBiological MarkersAcuteClinical TrialsBiomarker IdentificationCancer HospitalCancer Therapy Evaluation ProgramCancer TypeCell LineCellsChek1 GeneClinicClinical ResearchColon Cancer Cell Line
Grant awards (5)
Immunomodulatory Effects of Targeting DNA Repair with Novel Temozolomide Combinations in Colorectal Cancer$260,958
K08 · FY2025 · CA · contact PI
Immunomodulatory Effects of Targeting DNA Repair with Novel Temozolomide Combinations in Colorectal Cancer$260,958
K08 · FY2024 · CA · contact PI
Immunomodulatory Effects of Targeting DNA Repair with Novel Temozolomide Combinations in Colorectal Cancer$260,958
K08 · FY2023 · CA · contact PI
Immunomodulatory Effects of Targeting DNA Repair with Novel Temozolomide Combinations in Colorectal Cancer$260,958
K08 · FY2022 · CA · contact PI
Immunomodulatory Effects of Targeting DNA Repair with Novel Temozolomide Combinations in Colorectal Cancer$260,958
K08 · FY2021 · CA · contact PI